Zepbound became the first OSA drug to receive ... but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact ...

A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...

Eli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter results were rather uneventful, with the company already announcing ...

There’s no direct link between vision loss and taking the weight loss and diabetes drugs such as Ozempic, Wegovy, Mounjaro, ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...

After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (NYSE: LLY) announced ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

These data do not suggest a causal relationship between GLP-1 RA use and NAION events,” a spokesperson told The Post. Eli Lilly, the manufacturer of Mounjaro and Zepbound, did not immediately ...

Several patients using brand-name drugs like Ozempic, Wegovy, Mounjaro, and Zepbound experienced problems with their eyes, researchers said. Seven of the nine patients their study focused on had a ...